Trial · NCT01005251
Adverse events20
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 20
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | AZD3355 60 mg | 5 | 135 | |
| other | Diarrhoea | Gastrointestinal disorders | AZD3355 120 mg | 7 | 124 | |
| other | Diarrhoea | Gastrointestinal disorders | AZD3355 180 mg | 6 | 136 | |
| other | Diarrhoea | Gastrointestinal disorders | AZD3355 240 mg | 10 | 126 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 1 | 140 | |
| other | Paraesthesia | Nervous system disorders | AZD3355 60 mg | 8 | 135 | |
| other | Paraesthesia | Nervous system disorders | AZD3355 120 mg | 5 | 124 | |
| other | Paraesthesia | Nervous system disorders | AZD3355 180 mg | 10 | 136 | |
| other | Paraesthesia | Nervous system disorders | AZD3355 240 mg | 11 | 126 | |
| other | Paraesthesia | Nervous system disorders | Placebo | 8 | 140 | |
| serious | Non-Cardiac Chest Pain | General disorders | AZD3355 60 mg | 0 | 135 | |
| serious | Non-Cardiac Chest Pain | General disorders | AZD3355 120 mg | 0 | 124 | |
| serious | Non-Cardiac Chest Pain | General disorders | AZD3355 180 mg | 0 | 136 | |
| serious | Non-Cardiac Chest Pain | General disorders | AZD3355 240 mg | 1 | 126 | |
| serious | Non-Cardiac Chest Pain | General disorders | Placebo | 0 | 140 | |
| serious | Metastatic Gastric Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD3355 60 mg | 0 | 135 | |
| serious | Metastatic Gastric Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD3355 120 mg | 0 | 124 | |
| serious | Metastatic Gastric Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD3355 180 mg | 0 | 136 | |
| serious | Metastatic Gastric Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | AZD3355 240 mg | 0 | 126 | |
| serious | Metastatic Gastric Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Placebo | 1 | 140 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01005251/events